Atypical P2X7receptor pharmacology in two human osteoblast‐like cell lines
Authors:
Open Access
- 31 March 2009
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 156 (7) , 1124-1135
Abstract
Background and purpose: The expression and function of P2X7receptors in osteoclasts is well established, but less is known about their role in osteoblast‐like cells. A study in P2X7receptor knockout mice suggested the involvement of these receptors in bone formation. We have investigated the expression and pharmacology of several P2X receptors in two human osteosarcoma cell lines to see if they could be involved in bone turnover in man.Experimental approach: Reverse transcriptase‐polymerase chain reaction and Western blotting were used to study P2X2, P2X4and P2X7receptor expression at mRNA and protein levels, respectively, in human osteoblast‐like cells. P2X7receptor pharmacology was studied by measuring pore formation in the presence of different agonists and antagonists using the YO‐PRO 1 uptake method.Key results: P2X4and P2X7receptor mRNA and protein were found to be expressed by these cell lines. No evidence was found for P2X4/P2X7receptor heteropolymerization. 2′‐3′‐O‐(4‐benzoylbenzoyl)adenosine 5′‐triphosphate (DBzATP) was equipotent to ATP and the antagonists used were either ineffective or weakly blocked pore formation.Conclusions and implications: This study demonstrates that P2X4and P2X7receptors are expressed by human osteoblast‐like cells. The affinities of the different agonists suggest that the P2X7receptor is mainly responsible for pore formation although P2X4receptors may also be involved. The low affinity of DBzATP and the weak action of the antagonists support the previously described atypical pharmacology of the P2X7receptor in osteoblasts. Targeting the P2X7receptor in osteoblasts could represent a promising new treatment for bone diseases such as osteoporosis and rheumatoid arthritis.Keywords
This publication has 68 references indexed in Scilit:
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Basolateral P2X4-like receptors regulate the extracellular ATP-stimulated epithelial Na+channel activity in renal epitheliaAmerican Journal of Physiology-Renal Physiology, 2007
- Ivermectin potentiates ATP-induced ion currents in cortical neurones: Evidence for functional expression of P2X4 receptors?Neuroscience Letters, 2007
- Radioligand binding and functional responses of ligands for human recombinant adenosine A3receptorsAutonomic & Autacoid Pharmacology, 2006
- Human melanomas express functional P2X7 receptorsCell and tissue research, 2005
- Molecular properties of ATP-gated P2X receptor ion channelsTrends in Pharmacological Sciences, 2004
- Regulation of bone resorption and formation by purines and pyrimidinesTrends in Pharmacological Sciences, 2003
- Expression of a P2X7 Receptor by a Subpopulation of Human OsteoblastsJournal of Bone and Mineral Research, 2001
- Effects of antagonists at the human recombinant P2X7 receptorBritish Journal of Pharmacology, 1998
- Non‐genomic inhibition of human P2X7 purinoceptor by 17β‐oestradiolThe Journal of Physiology, 1998